RIVN, IBM, LCID, NVDA, LMT, JNJ, ARKK: Trending Stocks Today 25 Jan

By Kirsteen Mackay

Share:

In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

Investors prepare for another volatile day. S&P futures down 1.4%, back near worst levels, after US equities yesterday's dramatic late-day reversal.

Trending Stocks Today

US stock markets plunged into the red yesterday, with the S&P down nearly 4% at one point. But ultimately, the session closed green.

Tuesday should be another volatile day as bulls and bears battle it out.

Oil up. Gold flat. Bitcoin up.

NASDAQ S&P 500 BITCOIN
13,855.13 (+0.63%) 4,410.13 (+0.28%) 36,376.62 (+8.43%)

Here are some trending stocks:

  • Rivian (NASDAQ: RIVN) stock is down over 5% in pre-market trading. 

  • Japanese retailer Yoshitsu (NASDAQ: TKLF) tanked over 84% in yesterday's session. It is down again in after-hours trading.

  • IBM (NYSE: IBM) beat earnings estimates for revenue with its focus on hybrid cloud consulting and software, showing strength.

  • Snap (NYSE: SNAP) stock is down 32% year-to-date. It's been downgraded to neutral.

  • Snowflake (NASDAQ: SNOW) stock upgraded by Loop Capital.

  • Lucid (NASDAQ: LCID) stock is down pre-market.

  • eBay (NASDAQ: EBAY) launches authentication for trading cards.

  • Lockheed Martin's (NYSE: LMT) Aerojet buy draws criticism from FTC antitrust regulator.

  • Johnson & Johnson (NYSE: JNJ) reports Q4 and full-year 2021 results with higher quarterly sales.

  • Facebook (NASDAQ: FB) announced additional details on new reporting structure.

  • NVIDIA (NASDAQ: NVDA) reportedly plans to scrap its $40bn takeover of Arm.

  • Advanced Micro Devices (NASDAQ: AMD) is falling further, down 22% year-to-date.

  • Zions Bancorporation (NASDAQ: ZION) saw better loan growth and some takeaways noted upside risk from its asset-sensitive balance sheet.

  • Crane Co. (NYSE: CR) surpassed Q4 earnings and revenue estimates and declared dividend. It talked up continued performance momentum, though its 2022 guide is a bit below.

  • Inter Parfums (NASDAQ: IPAR) stock is up after raising Q4 outlook again with US division a standout, while also boosting 2022 guidance.

  • Allscripts Healthcare Solutions (NASDAQ: MDRX) positively preannounced and said it approved a new $250m share repurchase program. MDRX stock is up 6.4% pre-market.

  • ARK Innovation ETF (NYSEARCA: ARKK) stock rose 2.8% yesterday but is down again pre-market.

  • Dutch Bros. Coffee (NYSE: BROS) is down pre-market after a 10% gain yesterday.

  • Shroom stock Mind Medicine (MindMed) (NASDAQ: MNMD) dropped below a dollar last week and is down 38.5% year-to-date. It is up 12% pre-market.

  • SmileDirectClub (NASDAQ: SDC) is up 9% pre-market. The stock is boosted by the announcement of strategic actions to improve business performance and future growth.

  • Costco (NASDAQ: COST) is being watched as a popular inflation trade.

  • AAL American Airlines Group (NASDAQ: AAL) stock is trending.

  • Microsoft Corporation (NASDAQ: MSFT) reports Q2 2022 earnings after the close.

If you enjoyed reading this overview of what to expect in today's financial market, why not read our in-depth reports on ESG investing and Healthcare investing. Or check out our 12 investing themes for 2022.

Share:

In this article:

Industries:

Author: Kirsteen Mackay

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter